{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T08:51:28Z","timestamp":1790067088365,"version":"4.0.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2014,6,19]],"date-time":"2014-06-19T00:00:00Z","timestamp":1403136000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1245\/s10434-014-3844-x","type":"journal-article","created":{"date-parts":[[2014,6,19]],"date-time":"2014-06-19T09:15:03Z","timestamp":1403169303000},"page":"3931-3937","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["A Safety and Feasibility Study of an Allogeneic Colon Cancer Cell Vaccine Administered with a Granulocyte\u2013Macrophage Colony Stimulating Factor\u2013Producing Bystander Cell Line in Patients with Metastatic Colorectal Cancer"],"prefix":"10.1245","volume":"21","author":[{"given":"Lei","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barish H.","family":"Edil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin C.","family":"Soares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled","family":"El-Shami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer N.","family":"Uram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Judkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth","family":"Onners","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Laheru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Drew","family":"Pardoll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth M.","family":"Jaffee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard D.","family":"Schulick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,6,19]]},"reference":[{"key":"3844_CR1","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1158\/1055-9965.EPI-10-0437","volume":"19","author":"A Jemal","year":"2010","unstructured":"Jemal A, Center MM, DeSantis C, Ward EM. Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomark Prev. 2010;19:1893\u2013907.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"3844_CR2","doi-asserted-by":"crossref","first-page":"519","DOI":"10.6004\/jnccn.2013.0069","volume":"11","author":"AB Benson 3rd","year":"2013","unstructured":"Benson AB 3rd, Bekaii-Saab T, Chan E, et al. Localized colon cancer, version 3.2013: featured updates to the NCCN guidelines. J Natl Compr Cancer Netw. 2013;11:519\u201328.","journal-title":"J Natl Compr Cancer Netw"},{"key":"3844_CR3","doi-asserted-by":"crossref","first-page":"141","DOI":"10.6004\/jnccn.2013.0022","volume":"11","author":"AB Benson 3rd","year":"2013","unstructured":"Benson AB 3rd, Bekaii-Saab T, Chan E, et al. Metastatic colon cancer, version 3.2013: featured updates to the NCCN guidelines. J Natl Compr Cancer Netw. 2013;11:141\u201352.","journal-title":"J Natl Compr Cancer Netw."},{"key":"3844_CR4","doi-asserted-by":"crossref","unstructured":"Rothbarth J, van de Velde CJ. Treatment of liver metastases of colorectal cancer. Ann Oncol. 2005;16 Suppl 2:ii144\u20139.","DOI":"10.1093\/annonc\/mdi702"},{"key":"3844_CR5","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1003466","volume":"363","author":"FS Hodi","year":"2010","unstructured":"Hodi FS, O\u2019Day SJ, McDermott DF, et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med. 2010;363:711\u201323.","journal-title":"N Engl J Med."},{"key":"3844_CR6","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMoa1001294","volume":"363","author":"PW Kantoff","year":"2010","unstructured":"Kantoff PW, Higano CS, Shore ND, et al. Sipuleucel-T immunotherapy for castration-resistant prostate cancer. N Engl J Med. 2010;363:411\u201322.","journal-title":"N Engl J Med."},{"key":"3844_CR7","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1586\/14760584.4.3.329","volume":"4","author":"S Mosolits","year":"2005","unstructured":"Mosolits S, Nilsson B, Mellstedt H. Towards therapeutic vaccines for colorectal carcinoma: a review of clinical trials. Expert Rev Vaccines. 2005;4:329\u201350.","journal-title":"Expert Rev Vaccines"},{"key":"3844_CR8","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1245\/ASO.2003.10.006","volume":"10","author":"A Jain","year":"2003","unstructured":"Jain A, Slansky JE, Matey LC, et al. Synergistic effect of a granulocyte\u2013macrophage colony-stimulating factor\u2013transduced tumor vaccine and systemic interleukin-2 in the treatment of murine colorectal cancer hepatic metastases. Ann Surg Oncol. 2003;10:810\u201320.","journal-title":"Ann Surg Oncol."},{"key":"3844_CR9","doi-asserted-by":"crossref","unstructured":"Uyl-de Groot CA, Vermorken JB, Hanna MG Jr, et al. Immunotherapy with autologous tumor cell-BCG vaccine in patients with colon cancer: a prospective study of medical and economic benefits. Vaccine. 2005;23:2379\u201387.","DOI":"10.1016\/j.vaccine.2005.01.015"},{"key":"3844_CR10","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/nrc1630","volume":"5","author":"D Laheru","year":"2005","unstructured":"Laheru D, Jaffee EM. Immunotherapy for pancreatic cancer\u2014science driving clinical progress. Nat Rev Cancer. 2005;5:459\u201367.","journal-title":"Nat Rev Cancer."},{"key":"3844_CR11","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1200\/JCO.2001.19.1.145","volume":"19","author":"EM Jaffee","year":"2001","unstructured":"Jaffee EM, Hruban RH, Biedrzycki B, et al. Novel allogeneic granulocyte\u2013macrophage colony-stimulating factor\u2013secreting tumor vaccine for pancreatic cancer: a phase I trial of safety and immune activation. J Clin Oncol. 2001;19:145\u201356.","journal-title":"J Clin Oncol."},{"key":"3844_CR12","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1158\/1078-0432.CCR-07-0371","volume":"14","author":"D Laheru","year":"2008","unstructured":"Laheru D, Lutz E, Burke J, et al. Allogeneic granulocyte macrophage colony-stimulating factor\u2013secreting tumor immunotherapy alone or in sequence with cyclophosphamide for metastatic pancreatic cancer: a pilot study of safety, feasibility, and immune activation. Clin Cancer Res. 2008;14:1455\u201363.","journal-title":"Clin Cancer Res."},{"key":"3844_CR13","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/SLA.0b013e3181fd271c","volume":"253","author":"E Lutz","year":"2011","unstructured":"Lutz E, Yeo CJ, Lillemoe KD, et al. A lethally irradiated allogeneic granulocyte\u2013macrophage colony stimulating factor-secreting tumor vaccine for pancreatic adenocarcinoma. A phase II trial of safety, efficacy, and immune activation. Ann Surg. 2011;253:328\u201335.","journal-title":"Ann Surg."},{"key":"3844_CR14","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1089\/hum.1998.9.6-835","volume":"9","author":"MC Thomas","year":"1998","unstructured":"Thomas MC, Greten TF, Pardoll DM, Jaffee EM. Enhanced tumor protection by granulocyte\u2013macrophage colony-stimulating factor expression at the site of an allogeneic vaccine. Hum Gene Ther. 1998;9:835\u201343.","journal-title":"Hum Gene Ther."},{"key":"3844_CR15","doi-asserted-by":"crossref","first-page":"3539","DOI":"10.1073\/pnas.90.8.3539","volume":"90","author":"G Dranoff","year":"1993","unstructured":"Dranoff G, Jaffee E, Lazenby A, et al. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte\u2013macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc Natl Acad Sci USA. 1993;90:3539\u201343.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3844_CR16","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1089\/10430349950017347","volume":"10","author":"I Borrello","year":"1999","unstructured":"Borrello I, Sotomayor EM, Cooke S, Levitsky HI. A universal granulocyte\u2013macrophage colony-stimulating factor\u2013producing bystander cell line for use in the formulation of autologous tumor cell-based vaccines. Hum Gene Ther. 1999;10:1983\u201391.","journal-title":"Hum Gene Ther."},{"key":"3844_CR17","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0065-2776(06)90002-9","volume":"90","author":"CG Drake","year":"2006","unstructured":"Drake CG, Jaffee E, Pardoll DM. Mechanisms of immune evasion by tumors. Adv Immunol. 2006;90:51\u201381.","journal-title":"Adv Immunol."},{"key":"3844_CR18","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1002\/eji.200636459","volume":"36","author":"AH Banham","year":"2006","unstructured":"Banham AH, Powrie FM, Suri-Payer E. FOXP3\u00a0+\u00a0regulatory T cells: current controversies and future perspectives. Eur J Immunol. 2006;36:2832\u20136.","journal-title":"Eur J Immunol."},{"key":"3844_CR19","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1053\/j.gastro.2012.12.042","volume":"144","author":"L Zheng","year":"2013","unstructured":"Zheng L, Xue J, Jaffee EM, Habtezion A. Role of immune cells and immune-based therapies in pancreatitis and pancreatic ductal adenocarcinoma. Gastroenterology. 2013;144:1230\u201340.","journal-title":"Gastroenterology."},{"key":"3844_CR20","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1084\/jem.20042167","volume":"201","author":"AM Ercolini","year":"2005","unstructured":"Ercolini AM, Ladle BH, Manning EA, et al. Recruitment of latent pools of high-avidity CD8(+) T cells to the antitumor immune response. J Exp Med. 2005;201:1591\u2013602.","journal-title":"J Exp Med."},{"key":"3844_CR21","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.1752-8062.2008.00070.x","volume":"1","author":"IC Leao","year":"2008","unstructured":"Leao IC, Ganesan P, Armstrong TD, Jaffee EM. Effective depletion of regulatory T cells allows the recruitment of mesothelin-specific CD8 t cells to the antitumor immune response against a mesothelin-expressing mouse pancreatic adenocarcinoma. Clin Transl Sci. 2008;1:228\u2013239.","journal-title":"Clin Transl Sci."},{"key":"3844_CR22","doi-asserted-by":"crossref","first-page":"5911","DOI":"10.1200\/JCO.2009.23.3494","volume":"27","author":"LA Emens","year":"2009","unstructured":"Emens LA, Asquith JM, Leatherman JM, et al. Timed sequential treatment with cyclophosphamide, doxorubicin, and an allogeneic granulocyte\u2013macrophage colony-stimulating factor\u2013secreting breast tumor vaccine: a chemotherapy dose-ranging factorial study of safety and immune activation. J Clin Oncol. 2009;27:5911\u20138.","journal-title":"J Clin Oncol."},{"key":"3844_CR23","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1046\/j.1365-2249.2002.01863.x","volume":"129","author":"DL Shawler","year":"2002","unstructured":"Shawler DL, Bartholomew RM, Garrett MA, et al. Antigenic and immunologic characterization of an allogeneic colon carcinoma vaccine. Clin Exp Immunol. 2002;129:99\u2013106.","journal-title":"Clin Exp Immunol."},{"key":"3844_CR24","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.bbrc.2005.05.084","volume":"333","author":"Y Yamamoto","year":"2005","unstructured":"Yamamoto Y, Hirakawa E, Mori S, et al. Cleavage of carcinoembryonic antigen induces metastatic potential in colorectal carcinoma. Biochem Biophys Res Commun. 2005;333:223\u20139.","journal-title":"Biochem Biophys Res Commun."},{"key":"3844_CR25","first-page":"2309","volume":"3","author":"K Takenaga","year":"1997","unstructured":"Takenaga K, Nakanishi H, Wada K, et al. Increased expression of S100A4, a metastasis-associated gene, in human colorectal adenocarcinomas. Clin Cancer Res. 1997;3:2309\u201316.","journal-title":"Clin Cancer Res."},{"key":"3844_CR26","first-page":"1537","volume":"57","author":"JW Simons","year":"1997","unstructured":"Simons JW, Jaffee EM, Weber CE, et al. Bioactivity of autologous irradiated renal cell carcinoma vaccines generated by ex vivo granulocyte\u2013macrophage colony-stimulating factor gene transfer. Cancer Res. 1997;57:1537\u201346.","journal-title":"Cancer Res."},{"key":"3844_CR27","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1586\/erv.12.54","volume":"11","author":"DM Lubaroff","year":"2012","unstructured":"Lubaroff DM. Prostate cancer vaccines in clinical trials. Expert Rev Vaccines. 2012;11:857\u201368.","journal-title":"Expert Rev Vaccines."},{"key":"3844_CR28","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.urolonc.2005.08.021","volume":"24","author":"JW Simons","year":"2006","unstructured":"Simons JW, Sacks N. Granulocyte\u2013macrophage colony-stimulating factor\u2013transduced allogeneic cancer cellular immunotherapy: the GVAX vaccine for prostate cancer. Urol Oncol. 2006;24:419\u201324.","journal-title":"Urol Oncol."},{"key":"3844_CR29","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1007\/s00262-004-0640-7","volume":"54","author":"J Dittmann","year":"2005","unstructured":"Dittmann J, Keller-Matschke K, Weinschenk T, et al. CD8\u00a0+\u00a0T-cell response against MUC1-derived peptides in gastrointestinal cancer survivors. Cancer Immunol Immunother. 2005;54:750\u20138.","journal-title":"Cancer Immunol Immunother."},{"key":"3844_CR30","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/j.vaccine.2006.11.007","volume":"25","author":"P Mukherjee","year":"2007","unstructured":"Mukherjee P, Pathangey LB, Bradley JB, et al. MUC1-specific immune therapy generates a strong anti-tumor response in a MUC1-tolerant colon cancer model. Vaccine. 2007;25:1607\u201318.","journal-title":"Vaccine."},{"key":"3844_CR31","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/1471-2407-12-144","volume":"12","author":"CC Schimanski","year":"2012","unstructured":"Schimanski CC, Mohler M, Schon M, et al. LICC: L-BLP25 in patients with colorectal carcinoma after curative resection of hepatic metastases: a randomized, placebo-controlled, multicenter, multinational, double-blinded phase II trial. BMC Cancer. 2012;12:144.","journal-title":"BMC Cancer."},{"key":"3844_CR32","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1097\/SLA.0b013e318292919e","volume":"258","author":"MA Morse","year":"2013","unstructured":"Morse MA, Niedzwiecki D, Marshall JL, et al. A randomized phase II study of immunization with dendritic cells modified with poxvectors encoding CEA and MUC1 compared with the same poxvectors plus GM-CSF for resected metastatic colorectal cancer. Ann Surg. 2013;258:879\u201386.","journal-title":"Ann Surg."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-014-3844-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-014-3844-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-014-3844-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,11]],"date-time":"2019-08-11T14:35:05Z","timestamp":1565534105000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-014-3844-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,19]]},"references-count":32,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["3844"],"URL":"https:\/\/doi.org\/10.1245\/s10434-014-3844-x","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,19]]}}}